MENU
Moderators

Opens: September 1, 2020 at 10:30 AM SGT

A Paradigm Shift in Infectious Diseases: Lessons from a Pandemic

This 2-day virtual event organized across the Asia Pacific region aims to serve as a platform to share scientific knowledge and provide a discourse on the topic of infectious disease and immunity. Throughout the event, we will be focusing on the following themes:

  • Science of Infectious Disease 
  • Economics of Disease Control and Considerations for Public Health
  • Diagnosis & Innovation during a Pandemic  
  • Vaccine Development & Therapeutics

Esteemed speakers from these fields will be presenting their latest research, and you are encouraged to interact and have your questions answered during the Q&A and panel sessions.

At Merck, our purpose is to solve the toughest problems in life science by collaborating with the global scientific community – and through that, we aim to accelerate access to better health for people everywhere. We look forward to having you join us for this informative and timely event!


Speakers
  • Klaus R. Bischoff

    Head of Research Solutions of Life Science, Merck
    BIOGRAPHY
  • Patrick Schnider, PhD

    Head of Strategy, Business Development and Innovation
    BIOGRAPHY
  • Jerome H. Kim, MD

    Director General, International Vaccine Institute, South Korea
    BIOGRAPHY
  • Eng Eong Ooi, BMBS, PhD, FRCPath

    Deputy Director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, Singapore
    BIOGRAPHY
  • Dexi Chen, PhD

    Professor and Director, Beijing Institute of Hepatology; Capital Medical University, China
    BIOGRAPHY
  • Sujatha Sunil, PhD

    Group Leader, Vector Borne Diseases. International Centre for Genetic Engineering and Biotechnology, India
    BIOGRAPHY
  • Shee-Mei Lok, PhD

    Professor and Head of Virology Laboratory, Duke-NUS Medical School, Singapore
    BIOGRAPHY
  • John Cai, PhD

    Director for the Center for Health Management and Policy and Adjunct Professor, China Europe International Business School, China
    BIOGRAPHY
  • James Trauer, PhD

    Assoc Prof and Head of Epidemiological Modelling Unit for the School of Public Health and Preventative Medicine, Monash University, Australia
    BIOGRAPHY
  • Erfan Ibrahim, PhD

    Founder and CEO of The Bit Bazaar LLC, USA
    BIOGRAPHY
  • Anne Wyllie, PhD

    Research Scientist in Epidemiology, Yale School of Public Health, Yale University, USA
    BIOGRAPHY
  • Debojyoti Chakraborty, PhD

    Principal Scientist, EMBO Young Investigator, CSIR-Institute of Genomics and Integrative Biology
    BIOGRAPHY
  • Sidney Yee, PhD

    CEO, Diagnostics Development Hub and Senior Advisor at A*ccelerate, Singapore
    BIOGRAPHY
  • Tomoji Mashimo, PhD

    Director of Laboratory Animal Research Center, The University of Tokyo, Japan
    BIOGRAPHY
  • Rajiv Khanna, PhD, FAHMS

    Head of Tumour Oncology Laboratory, QIMR Berghofer Medical Research Institute, Australia
    BIOGRAPHY
  • Sanjay Singh, PhD

    CEO, Gennova Biopharmaceuticals Ltd, Pune, India
    BIOGRAPHY
  • Ryuichi Morishita, MD, PhD

    Professor of Department of Clinical Gene Therapy, Center of Medical Innovation and Translational Research School of Medicine, Osaka University, Japan
    BIOGRAPHY
  • Anissa Boumlic-Courtade, PhD

    Head of Global Vaccine & Plasma Segment, Bioprocessing, Process Solutions, Merck Life Sciences
    BIOGRAPHY
  • Krishna M. Ella, PhD

    Chairman & Managing Director Bharat Biotech International Limited, India
    BIOGRAPHY
  • Heather Hargett

    Head of Biology Technical Marketing Research Solutions, Merck Life Science
    BIOGRAPHY
  • Farhad Shafiei

    Head of Commercial Marketing - Asia Pacific Applied Solutions, Merck Life Science
    BIOGRAPHY
  • Vibhu Jain

    Head of Commercial Marketing-APAC Research Solutions, Merck Life Science
    BIOGRAPHY

Agenda

  • SEP 02, 2020 3:15 PM SGT

    The Development of Covaxin

    Krishna M. Ella, PhD
    Chairman & Managing Director Bharat Biotech International Limited, India
    BIOGRAPHY
  • Towards vaccine facility of the future: Shifting the paradigm of vaccine process development and manufacturing post pandemic
    SEP 02, 2020 2:45 PM SGT

    Towards vaccine facility of the future: Shifting the paradigm of vaccine process development and manufacturing post pandemic

    Anissa Boumlic-Courtade, PhD
    Head of Global Vaccine & Plasma Segment, Bioprocessing, Process Solutions, Merck Life Sciences
    BIOGRAPHY
  • SEP 02, 2020 2:00 PM SGT

    Development of Vaccine for Preventing Novel Coronavirus

    Ryuichi Morishita, MD, PhD
    Professor of Department of Clinical Gene Therapy, Center of Medical Innovation and Translational Research School of Medicine, Osaka University, Japan
    BIOGRAPHY
  • SEP 02, 2020 1:30 PM SGT

    Global consortium for Leishmania vaccine development

    Sanjay Singh, PhD
    CEO, Gennova Biopharmaceuticals Ltd, Pune, India
    BIOGRAPHY
  • SEP 02, 2020 12:00 PM SGT

    Combining immunodiagnostics and immunotherapy for clinical management of infectious complications in transplant patients

    Rajiv Khanna, PhD, FAHMS
    Head of Tumour Oncology Laboratory, QIMR Berghofer Medical Research Institute, Australia
    BIOGRAPHY
  • SEP 02, 2020 11:45 AM SGT

    Rapid and Accurate Detection of Novel Coronavirus SARS-Cov-2 Using Crispr-Cas3

    Tomoji Mashimo, PhD
    Director of Laboratory Animal Research Center, The University of Tokyo, Japan
    BIOGRAPHY
  • SEP 02, 2020 11:00 AM SGT

    Anatomy of a diagnostic test

    Sidney Yee, PhD
    CEO, Diagnostics Development Hub and Senior Advisor at A*ccelerate, Singapore
    BIOGRAPHY
  • SEP 02, 2020 10:30 AM SGT

    Connecting the dots between personalized and precision medicines

    Debojyoti Chakraborty, PhD
    Principal Scientist, EMBO Young Investigator, CSIR-Institute of Genomics and Integrative Biology
    BIOGRAPHY
  • SEP 02, 2020 10:00 AM SGT

    SalivaDirect Simple and sensitive molecular diagnostic test for SARS-CoV-2 surveillance with Live Q&A

    Anne Wyllie, PhD
    Research Scientist in Epidemiology, Yale School of Public Health, Yale University, USA
    BIOGRAPHY
  • SEP 01, 2020 3:45 PM SGT

    Comparative Analysis of Covid-19 Cumulative Infection Predictive Models

    Erfan Ibrahim, PhD
    Founder and CEO of The Bit Bazaar LLC, USA
    BIOGRAPHY
  • SEP 01, 2020 3:00 PM SGT

    The Challenges of Real-Time Modelling of a Pandemic

    James Trauer, PhD
    Assoc Prof and Head of Epidemiological Modelling Unit for the School of Public Health and Preventative Medicine, Monash University, Australia
    BIOGRAPHY
  • SEP 01, 2020 2:30 PM SGT

    Ten Healthcare Trends Post COVID-19

    John Cai, PhD
    Director for the Center for Health Management and Policy and Adjunct Professor, China Europe International Business School, China
    BIOGRAPHY
  • SEP 01, 2020 1:15 PM SGT

    The Interplay between Dengue Morphological Diversity and Antibody Recognition

    Shee-Mei Lok, PhD
    Professor and Head of Virology Laboratory, Duke-NUS Medical School, Singapore
    BIOGRAPHY
  • SEP 01, 2020 12:45 PM SGT

    Infectious Disease Epidemiology in current times: Germ theory inside the Black Box?

    Sujatha Sunil, PhD
    Group Leader, Vector Borne Diseases. International Centre for Genetic Engineering and Biotechnology, India
    BIOGRAPHY
  • SEP 01, 2020 12:00 PM SGT

    Immune Responses in Severe COVID-19 Patients

    Dexi Chen, PhD
    Professor and Director, Beijing Institute of Hepatology; Capital Medical University, China
    BIOGRAPHY
  • SEP 01, 2020 11:30 AM SGT

    What makes us sick - the virus or our response to infection?

    Eng Eong Ooi, BMBS, PhD, FRCPath
    Deputy Director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, Singapore
    BIOGRAPHY
  • COVID-19 Vaccine Development
    SEP 01, 2020 10:45 AM SGT

    COVID-19 Vaccine Development

    Jerome H. Kim, MD
    Director General, International Vaccine Institute, South Korea
    BIOGRAPHY
  • SEP 01, 2020 10:30 AM SGT

    Opening Session

    Klaus R. Bischoff
    Head of Research Solutions of Life Science, Merck
    Patrick Schnider, PhD
    Head of Strategy, Business Development and Innovation
  • Opening
  • SEP 01, 2020 10:30 AM SGT

    Opening Session

    Klaus R. Bischoff
    Head of Research Solutions of Life Science, Merck
    Patrick Schnider, PhD
    Head of Strategy, Business Development and Innovation
  • Key Note Presentation
  • COVID-19 Vaccine Development
    SEP 01, 2020 10:45 AM SGT

    COVID-19 Vaccine Development

    Jerome H. Kim, MD
    Director General, International Vaccine Institute, South Korea
    BIOGRAPHY
  • Science of Infectious Diseases
  • SEP 01, 2020 11:30 AM SGT

    What makes us sick - the virus or our response to infection?

    Eng Eong Ooi, BMBS, PhD, FRCPath
    Deputy Director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, Singapore
    BIOGRAPHY
  • SEP 01, 2020 12:00 PM SGT

    Immune Responses in Severe COVID-19 Patients

    Dexi Chen, PhD
    Professor and Director, Beijing Institute of Hepatology; Capital Medical University, China
    BIOGRAPHY
  • SEP 01, 2020 12:45 PM SGT

    Infectious Disease Epidemiology in current times: Germ theory inside the Black Box?

    Sujatha Sunil, PhD
    Group Leader, Vector Borne Diseases. International Centre for Genetic Engineering and Biotechnology, India
    BIOGRAPHY
  • SEP 01, 2020 1:15 PM SGT

    The Interplay between Dengue Morphological Diversity and Antibody Recognition

    Shee-Mei Lok, PhD
    Professor and Head of Virology Laboratory, Duke-NUS Medical School, Singapore
    BIOGRAPHY
  • Economics of Disease Control
  • SEP 01, 2020 2:30 PM SGT

    Ten Healthcare Trends Post COVID-19

    John Cai, PhD
    Director for the Center for Health Management and Policy and Adjunct Professor, China Europe International Business School, China
    BIOGRAPHY
  • SEP 01, 2020 3:00 PM SGT

    The Challenges of Real-Time Modelling of a Pandemic

    James Trauer, PhD
    Assoc Prof and Head of Epidemiological Modelling Unit for the School of Public Health and Preventative Medicine, Monash University, Australia
    BIOGRAPHY
  • SEP 01, 2020 3:45 PM SGT

    Comparative Analysis of Covid-19 Cumulative Infection Predictive Models

    Erfan Ibrahim, PhD
    Founder and CEO of The Bit Bazaar LLC, USA
    BIOGRAPHY
  • Diagnosis & Innovation during a Pandemic
  • SEP 02, 2020 10:00 AM SGT

    SalivaDirect Simple and sensitive molecular diagnostic test for SARS-CoV-2 surveillance with Live Q&A

    Anne Wyllie, PhD
    Research Scientist in Epidemiology, Yale School of Public Health, Yale University, USA
    BIOGRAPHY
  • SEP 02, 2020 10:30 AM SGT

    Connecting the dots between personalized and precision medicines

    Debojyoti Chakraborty, PhD
    Principal Scientist, EMBO Young Investigator, CSIR-Institute of Genomics and Integrative Biology
    BIOGRAPHY
  • SEP 02, 2020 11:00 AM SGT

    Anatomy of a diagnostic test

    Sidney Yee, PhD
    CEO, Diagnostics Development Hub and Senior Advisor at A*ccelerate, Singapore
    BIOGRAPHY
  • SEP 02, 2020 11:45 AM SGT

    Rapid and Accurate Detection of Novel Coronavirus SARS-Cov-2 Using Crispr-Cas3

    Tomoji Mashimo, PhD
    Director of Laboratory Animal Research Center, The University of Tokyo, Japan
    BIOGRAPHY
  • SEP 02, 2020 12:00 PM SGT

    Combining immunodiagnostics and immunotherapy for clinical management of infectious complications in transplant patients

    Rajiv Khanna, PhD, FAHMS
    Head of Tumour Oncology Laboratory, QIMR Berghofer Medical Research Institute, Australia
    BIOGRAPHY
  • Vaccine Development & Therapeutics
  • SEP 02, 2020 1:30 PM SGT

    Global consortium for Leishmania vaccine development

    Sanjay Singh, PhD
    CEO, Gennova Biopharmaceuticals Ltd, Pune, India
    BIOGRAPHY
  • SEP 02, 2020 2:00 PM SGT

    Development of Vaccine for Preventing Novel Coronavirus

    Ryuichi Morishita, MD, PhD
    Professor of Department of Clinical Gene Therapy, Center of Medical Innovation and Translational Research School of Medicine, Osaka University, Japan
    BIOGRAPHY
  • Towards vaccine facility of the future: Shifting the paradigm of vaccine process development and manufacturing post pandemic
    SEP 02, 2020 2:45 PM SGT

    Towards vaccine facility of the future: Shifting the paradigm of vaccine process development and manufacturing post pandemic

    Anissa Boumlic-Courtade, PhD
    Head of Global Vaccine & Plasma Segment, Bioprocessing, Process Solutions, Merck Life Sciences
    BIOGRAPHY
  • SEP 02, 2020 3:15 PM SGT

    The Development of Covaxin

    Krishna M. Ella, PhD
    Chairman & Managing Director Bharat Biotech International Limited, India
    BIOGRAPHY

Speakers


  • Klaus R. Bischoff

    Klaus R. Bischoff

    Head of Research Solutions of Life Science, Merck

    BIOGRAPHY
  • Patrick Schnider, PhD

    Patrick Schnider, PhD

    Head of Strategy, Business Development and Innovation

    BIOGRAPHY
  • Jerome H. Kim, MD

    Jerome H. Kim, MD

    Director General, International Vaccine Institute, South Korea

    BIOGRAPHY
  • Eng Eong Ooi, BMBS, PhD, FRCPath

    Eng Eong Ooi, BMBS, PhD, FRCPath

    Deputy Director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, Singapore

    BIOGRAPHY
  • Dexi Chen, PhD

    Dexi Chen, PhD

    Professor and Director, Beijing Institute of Hepatology; Capital Medical University, China

    BIOGRAPHY
  • Sujatha Sunil, PhD

    Sujatha Sunil, PhD

    Group Leader, Vector Borne Diseases. International Centre for Genetic Engineering and Biotechnology, India

    BIOGRAPHY
  • Shee-Mei Lok, PhD

    Shee-Mei Lok, PhD

    Professor and Head of Virology Laboratory, Duke-NUS Medical School, Singapore

    BIOGRAPHY
  • John Cai, PhD

    John Cai, PhD

    Director for the Center for Health Management and Policy and Adjunct Professor, China Europe International Business School, China

    BIOGRAPHY
  • James Trauer, PhD

    James Trauer, PhD

    Assoc Prof and Head of Epidemiological Modelling Unit for the School of Public Health and Preventative Medicine, Monash University, Australia

    BIOGRAPHY
  • Erfan Ibrahim, PhD

    Erfan Ibrahim, PhD

    Founder and CEO of The Bit Bazaar LLC, USA

    BIOGRAPHY
  • Anne Wyllie, PhD

    Anne Wyllie, PhD

    Research Scientist in Epidemiology, Yale School of Public Health, Yale University, USA

    BIOGRAPHY
  • Debojyoti Chakraborty, PhD

    Debojyoti Chakraborty, PhD

    Principal Scientist, EMBO Young Investigator, CSIR-Institute of Genomics and Integrative Biology

    BIOGRAPHY
  • Sidney Yee, PhD

    Sidney Yee, PhD

    CEO, Diagnostics Development Hub and Senior Advisor at A*ccelerate, Singapore

    BIOGRAPHY
  • Tomoji Mashimo, PhD

    Tomoji Mashimo, PhD

    Director of Laboratory Animal Research Center, The University of Tokyo, Japan

    BIOGRAPHY
  • Rajiv Khanna, PhD, FAHMS

    Rajiv Khanna, PhD, FAHMS

    Head of Tumour Oncology Laboratory, QIMR Berghofer Medical Research Institute, Australia

    BIOGRAPHY
  • Sanjay Singh, PhD

    Sanjay Singh, PhD

    CEO, Gennova Biopharmaceuticals Ltd, Pune, India

    BIOGRAPHY
  • Ryuichi Morishita, MD, PhD

    Ryuichi Morishita, MD, PhD

    Professor of Department of Clinical Gene Therapy, Center of Medical Innovation and Translational Research School of Medicine, Osaka University, Japan

    BIOGRAPHY
  • Anissa Boumlic-Courtade, PhD

    Anissa Boumlic-Courtade, PhD

    Head of Global Vaccine & Plasma Segment, Bioprocessing, Process Solutions, Merck Life Sciences

    BIOGRAPHY
  • Krishna M. Ella, PhD

    Krishna M. Ella, PhD

    Chairman & Managing Director Bharat Biotech International Limited, India

    BIOGRAPHY
  • Heather Hargett

    Heather Hargett

    Head of Biology Technical Marketing Research Solutions, Merck Life Science

    BIOGRAPHY
  • Farhad Shafiei

    Farhad Shafiei

    Head of Commercial Marketing - Asia Pacific Applied Solutions, Merck Life Science

    BIOGRAPHY
  • Vibhu Jain

    Vibhu Jain

    Head of Commercial Marketing-APAC Research Solutions, Merck Life Science

    BIOGRAPHY
Gamification

Thanks in advance for joining us for this important event. As a token of our appreciation, we are offering giveaway items which event attendees can win by accumulating participation points over the course of the event. Attendees will earn points by watching presentations, engaging with our multimedia information boards, downloading educational content, and sharing information with fellow participants. Our virtual hall will include a leaderboard where you can accumulate points as you engage in and around our event. Those who accumulate the highest number of points will receive a gift. Simply log in on the first day of the event to view a listing of opportunities of engagement. Good luck and thanks again for joining us!

Help